Givaudan shares approach record high as fine fragrance growth reaches 15.3%

Givaudan SA (SIX Swiss Exchange: GIVN) has moved close to a 52-week high after reporting accelerating third-quarter sales, with its Fragrance & Beauty division continuing to materially outperform Taste & Wellbeing. Group sales reached CHF5.89 billion for the first nine months of 2026, up 5.2% like for like and 2.6% in reported Swiss francs, while Fragrance & Beauty grew 8.8% like for like to CHF3.15 billion. Fine Fragrance led the portfolio with 15.3% nine-month like-for-like growth, supported by strong consumer demand for perfume and continued investment by beauty companies in premium fragrance launches. Taste & Wellbeing increased only 1.5% like for like over the same period, creating a widening performance gap between the two divisions. Givaudan shares closed at CHF3,915 on October 16, almost 14% above their October 9 level and less than 1% below the CHF3,948 52-week high, putting pressure on the company to demonstrate that fragrance momentum can remain strong enough to support elevated expectations.

Why is fine fragrance growing much faster than the rest of Givaudan’s ingredient portfolio?

Fine Fragrance sales increased 15.3% like for like over the first nine months, extending a multiyear period in which perfume has outperformed many other discretionary consumer categories. Luxury and prestige beauty companies continue launching fragrances at high frequency, while consumers have treated scent as a relatively accessible premium purchase compared with larger luxury items. Strong innovation and social-media discovery have also expanded the category beyond traditional seasonal launches.

Givaudan benefits without having to predict which perfume brand will win the consumer contest. It develops fragrance compounds for numerous customers, giving it exposure to category growth across luxury groups, beauty companies and regional brands. This supplier position can be attractive when the number of launches and overall category spending increase simultaneously.

Consumer Products fragrances also performed strongly, rising 9.3% like for like during the nine-month period. That broadens the growth story beyond prestige bottles because fragrance is incorporated into household products, personal care and other consumer categories. The division is therefore benefiting from both premium perfume demand and the wider consumer preference for differentiated scents.

Fragrance Ingredients and Active Beauty declined 2.5% like for like, showing that not every part of the segment is participating equally. Givaudan’s headline Fragrance & Beauty growth is being driven primarily by fragrance creation rather than a uniform acceleration across every beauty-related activity.

How much did Givaudan’s growth accelerate during the third quarter compared with the first half?

Third-quarter performance was materially stronger than the nine-month average. Group third-quarter sales reached approximately CHF2.09 billion, representing 8.6% like-for-like growth, while Fragrance & Beauty increased 13.5% like for like. Taste & Wellbeing also improved to 3.5% like-for-like growth, indicating that momentum broadened somewhat even though the fragrance division remained the stronger engine.

The acceleration matters because Givaudan began 2026 more slowly. First-quarter group like-for-like sales grew only 2.8%, with Taste & Wellbeing declining 0.4%. Nine-month figures now show 5.2% group growth, confirming that subsequent quarters improved rather than relying simply on favourable prior-year comparisons in one reporting period.

Acquisitions have contributed but do not explain most of the underlying improvement. Belle Aire Creations added CHF62 million of sales during the nine-month period and Vollmens Fragrances contributed CHF20 million, taking total acquisition impact in Fragrance & Beauty to 2.8%. The company’s reported like-for-like growth measure excludes those portfolio effects, meaning the 8.8% Fragrance & Beauty increase primarily reflects organic performance.

Currency remains a headwind. Foreign-exchange movements reduced reported group growth by about four percentage points over nine months, which is why 5.2% like-for-like growth translated into only 2.6% growth in Swiss francs. Sustained organic momentum is therefore carrying more of the investment case than the reported revenue figure alone suggests.

Why is Givaudan’s Taste & Wellbeing division lagging while fragrance demand accelerates?

Taste & Wellbeing generated CHF2.74 billion of nine-month sales, down 2.8% in reported Swiss francs and up only 1.5% like for like. North America was particularly weak, with like-for-like sales declining 3.3%, while Asia Pacific provided stronger growth. The division is exposed to food and beverage customer volumes that currently lack the same category momentum visible in prestige fragrance.

The different performance illustrates one advantage of Givaudan’s portfolio. Fragrance demand can compensate when food and beverage applications are softer, reducing dependence on a single consumer category. That diversification becomes particularly valuable because customer inventory cycles, raw-material pricing and product launches do not move simultaneously across beauty, household products and packaged food.

It also limits how aggressively investors should extrapolate the fragrance boom to the whole company. Fragrance & Beauty now generates slightly more than half of group sales, but Taste & Wellbeing remains a substantial operation. A durable group-level acceleration would become more convincing if Taste & Wellbeing moved closer to Givaudan’s medium-term growth range while Fragrance & Beauty remained strong.

Management continues adjusting prices to compensate for higher input costs, making customer acceptance another variable. Pricing can protect margins when raw materials become more expensive, but excessive increases can pressure volumes or encourage reformulation. Givaudan’s continued positive like-for-like growth suggests that it has so far balanced those pressures at group level.

Is Givaudan’s share price now demanding unusually strong execution after the fragrance-led rally?

Givaudan closed at CHF3,915 on October 16 after trading as high as CHF3,948 during the previous session, which matched the upper end of its 52-week range. The stock has risen about 13.6% from its October 9 close near CHF3,448 and roughly 20% from mid-September levels. The sharp rerating followed the October 13 nine-month update, when the shares posted their largest move of the recent period.

The market reaction reflects stronger-than-expected momentum rather than a change in Givaudan’s long-term strategic targets. The company continues to aim for average like-for-like sales growth of 4% to 6% and average adjusted free cash flow above 12% over its five-year strategy period. Nine-month group growth of 5.2% sits comfortably inside that range, while third-quarter growth ran materially faster.

Trading near a 52-week high changes the burden of evidence. A lower valuation can absorb some operational disappointment, whereas a stock priced for sustained momentum becomes more sensitive to slowing fine-fragrance demand, customer destocking or weaker margin conversion. January’s full-year results will therefore need to show that strong sales are translating into cash flow and profitability rather than being achieved at the expense of pricing or working capital.

Givaudan also continues to pursue acquisitions aligned with its strategic priorities. Belle Aire Creations and Vollmens are already contributing revenue, and further transactions could extend capabilities or geographic reach. Acquisition discipline becomes increasingly important when organic growth is strong because management has less need to pay aggressively simply to manufacture top-line expansion.

Can the global perfume boom remain strong enough to keep supporting Givaudan’s valuation?

Fragrance has several structural supports, including premiumisation, high product-launch activity and relatively low consumer entry prices compared with fashion or jewellery. Beauty companies also increasingly use fragrance as a brand-extension category, while niche and regional labels continue taking share from traditional houses. Those forces create a broad customer base for suppliers such as Givaudan.

Category growth will eventually normalise, making portfolio breadth important. Givaudan does not need fine fragrance to grow at 15% indefinitely if Consumer Products, Taste & Wellbeing and acquisitions can provide additional growth. The risk arises if perfume slows before the weaker businesses accelerate, leaving group growth below the expectations now embedded in the share price.

The January 27 full-year results will provide the next comprehensive proof point. Maintaining fragrance momentum, showing further improvement in Taste & Wellbeing and converting growth into strong adjusted free cash flow would support the recent rerating. A material deceleration in fine fragrance without compensating improvement elsewhere would expose how dependent 2026 momentum has become on one exceptionally strong category.

What are the key takeaways from Givaudan’s nine-month fragrance and beauty growth?

• Givaudan generated CHF5.89 billion of sales during the first nine months of 2026.
• Group sales increased 5.2% like for like despite significant negative currency effects.
• Fragrance & Beauty grew 8.8% like for like to CHF3.15 billion.
• Fine Fragrance was the standout category with 15.3% like-for-like growth.
• Consumer Products fragrances also grew strongly at 9.3%.
• Fragrance Ingredients and Active Beauty declined 2.5%, showing that beauty-related performance was not uniformly strong.
• Taste & Wellbeing grew only 1.5% like for like over nine months, although third-quarter growth improved to 3.5%.
• Third-quarter group like-for-like growth accelerated to 8.6%, materially above the nine-month average.
• $GIVN closed at CHF3,915 on October 16, less than 1% below its CHF3,948 52-week high.
• January 27 full-year results will test whether fragrance-led growth is translating into the cash generation needed to support the recent valuation rerating.